Immunogenicity of One Dose of Gardasil and One Dose of Gardasil-9

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

32 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-10-01

Study Completion Date

2016-12-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will assess the immunogenicity of one dose of Gardasil and one dose of Gardasil-9

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Persistence of Immune Response Six Years After One Dose of 9vHPV Vaccine Among Male and Female Students

NCT07156084

HPV Vaccine

RECRUITING PHASE4

Immunogenicity and Safety of Gardasil-9 and Cervarix

NCT02567955

HPV Vaccines Immunogenicity and Safety

COMPLETED PHASE3

An Extended Follow-Up Study of the HPV Vaccine Delayed Booster Trial

NCT04688476

HPV-associated Cancer

ACTIVE_NOT_RECRUITING

Vaccination Against Human Papillomavirus (HPV) With the 9-valent Vaccine in HIV-positive Women (the Papillon Study)

NCT03391921

HPV - Anogenital Human Papilloma Virus Infection HIV Infections

ACTIVE_NOT_RECRUITING PHASE4

Study of an Investigational Vaccine in Pre-Adolescents and Adolescents (Gardasil)(V501-016)

NCT00092495

Cervical Cancer Genital Warts

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a one group exploratory study.

The main objective of this study is to assess the persistance of anti-HPV after a single dose Gardasil and the effect of one dose of Gardasil-9 when administered 3-8 years later.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Human Papillomavirus Vaccines

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Single group exploratory study

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Gardasil and Gardasil-9

Group Type EXPERIMENTAL

Gardasil and Gardasil-9

Intervention Type BIOLOGICAL

All subjects will receive one dose of Gardasil-9. Blodd samples for serological testing will be collected just before and one month post Gardasil-9 administration.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Gardasil and Gardasil-9

All subjects will receive one dose of Gardasil-9. Blodd samples for serological testing will be collected just before and one month post Gardasil-9 administration.

Intervention Type BIOLOGICAL